Nolan Priedigkeit, MD, PhD, attended the University of Oregon for his undergraduate studies and received an MD/PhD from the University of Pittsburgh School of Medicine. His thesis applied translational genomics to discover and functionally characterize acquired molecular dependencies in advanced breast cancers. He completed an Internal Medicine residency at Brigham & Women’s Hospital and is currently a Medical Oncology Fellow at Dana-Farber Cancer Institute and a Postdoctoral Scholar at the Broad Institute of MIT & Harvard. Clinically, he sees patients with breast cancer with a particular focus on those afflicted with metastatic disease. His research aims to merge computational and genomic sciences with technology development to make an impact on how we understand and treat advanced cancers.